Cargando…
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity
BACKGROUND: Ebola hemorrhagic fever is caused by the Ebola filovirus (EBOV), which is one of the most aggressive infectious agents known worldwide. The EBOV pathogenesis starts with uncontrolled viral replication and subversion of both the innate and adaptive host immune response. The multifunctiona...
Autores principales: | Flego, Michela, Frau, Aldo, Accardi, Luisa, Mallano, Alessandra, Ascione, Alessandro, Gellini, Mara, Fanunza, Elisa, Vella, Stefano, Di Bonito, Paola, Tramontano, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727353/ https://www.ncbi.nlm.nih.gov/pubmed/31488108 http://dx.doi.org/10.1186/s12896-019-0554-2 |
Ejemplares similares
-
Relevance of Ebola virus VP35 homo-dimerization on the type I
interferon cascade inhibition
por: Di Palma, Francesco, et al.
Publicado: (2019) -
dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35
por: Zinzula, Luca, et al.
Publicado: (2012) -
Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling
por: Fanunza, Elisa, et al.
Publicado: (2018) -
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules
por: Fanunza, Elisa, et al.
Publicado: (2018) -
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8(+) T lymphocyte exhaustion
por: Ascione, Alessandro, et al.
Publicado: (2019)